These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 19327399)

  • 1. HIV-1 gp120 neurotoxicity proximally and at a distance from the point of exposure: protection by rSV40 delivery of antioxidant enzymes.
    Louboutin JP; Agrawal L; Reyes BA; Van Bockstaele EJ; Strayer DS
    Neurobiol Dis; 2009 Jun; 34(3):462-76. PubMed ID: 19327399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic neurotoxicity of HIV-1 gp120: reactive oxygen species as signaling intermediates.
    Agrawal L; Louboutin JP; Marusich E; Reyes BA; Van Bockstaele EJ; Strayer DS
    Brain Res; 2010 Jan; 1306():116-30. PubMed ID: 19815008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protecting neurons from HIV-1 gp120-induced oxidant stress using both localized intracerebral and generalized intraventricular administration of antioxidant enzymes delivered by SV40-derived vectors.
    Louboutin JP; Agrawal L; Reyes BA; Van Bockstaele EJ; Strayer DS
    Gene Ther; 2007 Dec; 14(23):1650-61. PubMed ID: 17914406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidant enzyme gene delivery to protect from HIV-1 gp120-induced neuronal apoptosis.
    Agrawal L; Louboutin JP; Reyes BA; Van Bockstaele EJ; Strayer DS
    Gene Ther; 2006 Dec; 13(23):1645-56. PubMed ID: 16871233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 gp120-induced neuroinflammation: relationship to neuron loss and protection by rSV40-delivered antioxidant enzymes.
    Louboutin JP; Reyes BA; Agrawal L; Van Bockstaele EJ; Strayer DS
    Exp Neurol; 2010 Jan; 221(1):231-45. PubMed ID: 19913017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood-brain barrier abnormalities caused by exposure to HIV-1 gp120--protection by gene delivery of antioxidant enzymes.
    Louboutin JP; Reyes BA; Agrawal L; Maxwell CR; Van Bockstaele EJ; Strayer DS
    Neurobiol Dis; 2010 May; 38(2):313-25. PubMed ID: 20219678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrastriatal administration of human immunodeficiency virus-1 glycoprotein 120 reduces glial cell-line derived neurotrophic factor levels and causes apoptosis in the substantia nigra.
    Nosheny RL; Bachis A; Aden SA; De Bernardi MA; Mocchetti I
    J Neurobiol; 2006 Oct; 66(12):1311-21. PubMed ID: 16967504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 gp120 upregulates matrix metalloproteinases and their inhibitors in a rat model of HIV encephalopathy.
    Louboutin JP; Reyes BA; Agrawal L; Van Bockstaele EJ; Strayer DS
    Eur J Neurosci; 2011 Dec; 34(12):2015-23. PubMed ID: 22092673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene delivery of antioxidant enzymes inhibits human immunodeficiency virus type 1 gp120-induced expression of caspases.
    Louboutin JP; Agrawal L; Reyes BA; van Bockstaele EJ; Strayer DS
    Neuroscience; 2012 Jul; 214():68-77. PubMed ID: 22531373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracisternal rSV40 administration provides effective pan-CNS transgene expression.
    Louboutin JP; Reyes BA; Agrawal L; Van Bockstaele EJ; Strayer DS
    Gene Ther; 2012 Jan; 19(1):114-8. PubMed ID: 21614027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rat model of human immunodeficiency virus 1 encephalopathy using envelope glycoprotein gp120 expression delivered by SV40 vectors.
    Louboutin JP; Agrawal L; Reyes BA; Van Bockstaele EJ; Strayer DS
    J Neuropathol Exp Neurol; 2009 May; 68(5):456-73. PubMed ID: 19525894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 gp120-induced injury to the blood-brain barrier: role of metalloproteinases 2 and 9 and relationship to oxidative stress.
    Louboutin JP; Agrawal L; Reyes BA; Van Bockstaele EJ; Strayer DS
    J Neuropathol Exp Neurol; 2010 Aug; 69(8):801-16. PubMed ID: 20613638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 Tat neurotoxicity: a model of acute and chronic exposure, and neuroprotection by gene delivery of antioxidant enzymes.
    Agrawal L; Louboutin JP; Reyes BA; Van Bockstaele EJ; Strayer DS
    Neurobiol Dis; 2012 Feb; 45(2):657-70. PubMed ID: 22036626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing HIV-1 Tat-induced neuronal apoptosis using antioxidant enzymes: mechanistic and therapeutic implications.
    Agrawal L; Louboutin JP; Strayer DS
    Virology; 2007 Jul; 363(2):462-72. PubMed ID: 17336361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-methyl-4-phenylpyridinium neurotoxicity is attenuated by adenoviral gene transfer of human Cu/Zn superoxide dismutase.
    Barkats M; Horellou P; Colin P; Millecamps S; Faucon-Biguet N; Mallet J
    J Neurosci Res; 2006 Feb; 83(2):233-42. PubMed ID: 16353238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathological and electrophysiological indices of rotenone-evoked dopaminergic toxicity: Neuroprotective effects of acetyl-L-carnitine.
    Sarkar S; Gough B; Raymick J; Beaudoin MA; Ali SF; Virmani A; Binienda ZK
    Neurosci Lett; 2015 Oct; 606():53-9. PubMed ID: 26321151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Protective effect of alkaloids from Piper longum in rat dopaminergic neuron injury of 6-OHDA-induced Parkinson's disease].
    Zheng L; Wang H; Ba YY; Liu HL; Wang M; Guo WW; Wu X; Yang H
    Zhongguo Zhong Yao Za Zhi; 2014 May; 39(9):1660-5. PubMed ID: 25095380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal transfer of the human Cu/Zn superoxide dismutase gene increases the resistance of dopaminergic neurons to 6-hydroxydopamine.
    Barkats M; Millecamps S; Bilang-Bleuel A; Mallet J
    J Neurochem; 2002 Jul; 82(1):101-9. PubMed ID: 12091470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain-derived neurotrophic factor prevents the nigrostriatal degeneration induced by human immunodeficiency virus-1 glycoprotein 120 in vivo.
    Nosheny RL; Ahmed F; Yakovlev A; Meyer EM; Ren K; Tessarollo L; Mocchetti I
    Eur J Neurosci; 2007 Apr; 25(8):2275-84. PubMed ID: 17445226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
    Saravanan KS; Sindhu KM; Senthilkumar KS; Mohanakumar KP
    Neurochem Int; 2006 Jul; 49(1):28-40. PubMed ID: 16490285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.